Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD · Real-Time Price · USD
1.170
-0.020 (-1.68%)
At close: Jun 27, 2025, 4:00 PM
1.160
-0.010 (-0.85%)
After-hours: Jun 27, 2025, 7:59 PM EDT
Lucid Diagnostics Market Cap
Lucid Diagnostics has a market cap or net worth of $126.59 million as of June 27, 2025. Its market cap has increased by 224.20% in one year.
Market Cap
126.59M
Enterprise Value
135.79M
1-Year Change
224.20%
Ranking
Category
Stock Price
$1.17
Market Cap Chart
Since the IPO on October 14, 2021, Lucid Diagnostics's market cap has decreased from $514.14M to $126.59M, a decrease of -75.38%. That is a compound annual growth rate of -31.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 128.75M | 183.64% |
| Dec 31, 2024 | 45.39M | -23.95% |
| Dec 29, 2023 | 59.69M | 12.22% |
| Dec 30, 2022 | 53.19M | -73.09% |
| Dec 31, 2021 | 197.66M | -61.55% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 703.43B |
| Johnson & Johnson | 367.60B |
| AbbVie | 328.20B |
| Novo Nordisk | 299.93B |
| UnitedHealth Group | 280.53B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 233.54B |
| AstraZeneca | 215.99B |